Amarin Corporation plc (NASDAQ: AMRN) is 48.76% higher on its value in year-to-date trading and has touched a low of $1.04 and a high of $3.82 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AMRN stock was last observed hovering at around $1.82 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $1.80, the stock is 19.13% and 35.32% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.14 million and changing -1.10% at the moment leaves the stock 16.24% off its SMA200. AMRN registered -43.93% loss for a year compared to 6-month loss of 40.62%.
The stock witnessed a 44.00% gain in the last 1 month and extending the period to 3 months gives it a 65.14%, and is -13.88% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.30% over the week and 8.81% over the month.
Amarin Corporation plc (AMRN) has around 560 employees, a market worth around $734.83M and $423.40M in sales. Profit margin for the company is -21.70%. Distance from 52-week low is 73.08% and -52.82% from its 52-week high. The company has generated returns on investments over the last 12 months (1.00%).
The EPS is expected to grow by 140.70% this year.
Amarin Corporation plc (AMRN) Top Institutional Holders
The shares outstanding are 404.61M, and float is at 381.31M with Short Float at 3.47%.
Amarin Corporation plc (AMRN) Insider Activity
A total of 11 insider transactions have happened at Amarin Corporation plc (AMRN) in the last six months, with sales accounting for 6 and purchases happening 5 times. The most recent transaction is an insider purchase by WOLD OLSEN PER,the company’sDirector. SEC filings show that WOLD OLSEN PER bought 55,000 shares of the company’s common stock on Jun 13 at a price of $1.69 per share for a total of $92730.0. Following the purchase, the insider now owns 0.15 million shares.
Amarin Corporation plc (AMRN): Who are the competitors?
The company’s main competitors (and peers) include AstraZeneca PLC (AZN) that is trading 12.36% up over the past 12 months and Ionis Pharmaceuticals Inc. (IONS) that is 31.36% higher over the same period. AbbVie Inc. (ABBV) is 11.67% up on the 1-year trading charts.